← Back to home
Comparison · Analytics

GeneNMF vs medrobust

A side-by-side editorial comparison of GeneNMF and medrobust — release velocity, themes, recent moves, and the top alternatives to consider.

GeneNMF vs medrobust: at a glance

FeatureGeneNMFmedrobust
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themessingle-cell-genomics, nmf, gene-programs, bioinformaticscausal mediation, partial identification, misclassification, sensitivity analysis
Last editorial update1h ago7h ago
WebsiteVisit →Visit →

What is GeneNMF?

GeneNMF rebuilt how it derives meta-programs, changing every result it had produced.

GeneNMF applies non-negative matrix factorization to single-cell expression data to find gene programs, then consolidates programs recurring across samples into meta-programs. Version 0.6.0 replaced the consolidation method: instead of reducing each program to a gene set and taking a consensus, it retains full gene weight vectors and compares them by cosine similarity. Later releases have built reporting and control around that core — a metaprogram composition matrix showing which samples contributed, custom signature databases for enrichment testing, and the ability to drop meta-programs from results.

Read the full GeneNMF trajectory →

What is medrobust?

medrobust made its partial-identification bounds usable by giving them confidence intervals.

medrobust computes partial-identification bounds for mediation effects when exposure or mediator is differentially misclassified, part of the Data-Wise mediationverse. Its 0.2.0 release corrected three estimator defects against population oracles and added Imbens-Manski confidence intervals for the bounds; the two releases since have paired each identification path with a real public-domain dataset and a worked vignette. CRAN is deferred, with distribution through GitHub and r-universe.

Read the full medrobust trajectory →

GeneNMF vs medrobust: editorial side-by-side

G
GeneNMF
ANALYTICS
0.0

GeneNMF rebuilt how it derives meta-programs, changing every result it had produced.

◆ Current state

GeneNMF applies non-negative matrix factorization to single-cell expression data to find gene programs, then consolidates programs recurring across samples into meta-programs. Version 0.6.0 replaced the consolidation method: instead of reducing each program to a gene set and taking a consensus, it retains full gene weight vectors and compares them by cosine similarity. Later releases have built reporting and control around that core — a metaprogram composition matrix showing which samples contributed, custom signature databases for enrichment testing, and the ability to drop meta-programs from results.

◆ Where it's heading

The package is moving from producing meta-programs to letting users interrogate and constrain how they were formed. Composition matrices, the drop function and downsampled similarity heatmaps all serve inspection rather than derivation. The parameters added alongside the 0.6.0 rewrite — specificity weighting, cumulative weight thresholds, confidence defined as the fraction of programs containing a gene — turn what were fixed internal choices into stated, tunable ones.

◆ Prediction

Recent releases have been fixes and compatibility work rather than method changes, so the core approach appears settled. The dependency on an RcppML version not on CRAN is the loose end most likely to force the next release.

M
medrobust
ANALYTICS
0.0

medrobust made its partial-identification bounds usable by giving them confidence intervals.

◆ Current state

medrobust computes partial-identification bounds for mediation effects when exposure or mediator is differentially misclassified, part of the Data-Wise mediationverse. Its 0.2.0 release corrected three estimator defects against population oracles and added Imbens-Manski confidence intervals for the bounds; the two releases since have paired each identification path with a real public-domain dataset and a worked vignette. CRAN is deferred, with distribution through GitHub and r-universe.

◆ Where it's heading

The pattern is deliberate and symmetric: 0.3.0 shipped the mediator-side example on NCHS natality data, 0.4.0 its exposure-side mirror on NHANES, each demonstrating what the bounds do when reporting accuracy is allowed to depend on the outcome. Alongside that runs a consistent concern with failing usefully rather than loudly — bound_ne() returns NA bounds with a machine-readable reason and a typed condition instead of aborting, so a simulation replicate is recorded rather than lost, and non-finite endpoint standard errors produce a documented NA rather than a silent one. That is a package expecting to be run thousands of times inside someone else's loop.

◆ Prediction

Both identification paths now have a dataset, a vignette and interval coverage, so the next release is most likely the deferred CRAN submission rather than new methodology.

Alternatives to GeneNMF and medrobust

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either GeneNMF or medrobust.

See all GeneNMF alternatives → · See all medrobust alternatives →

Recent activity from GeneNMF and medrobust

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 2mo agomedrobustNHANES exposure-side misclassification example dataset
  2. 2mo agomedrobustNatality example dataset; bounds degrade instead of aborting
  3. 2mo agomedrobustBounds corrected against oracles; Imbens-Manski intervals added
  4. 11mo agoGeneNMFSingle-sample runs fixed; gene weight definition refined
  5. 1y agoGeneNMFMetaprogram composition exposed and custom signature DBs supported
  6. 1y agoGeneNMFSimilarity heatmap downsampling and meta-program removal
  7. 2y agoGeneNMFMeta-programs rebuilt on gene weight vectors and cosine similarity
  8. 2y agoGeneNMFFirst stable release published to CRAN

Frequently asked questions

What is the difference between GeneNMF and medrobust?

They serve adjacent needs but don't currently overlap on shipped themes. GeneNMF and medrobust are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is GeneNMF better than medrobust?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. GeneNMF and medrobust are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to GeneNMF?

Top GeneNMF alternatives in Analytics are ranked by recent ship velocity. Browse the "GeneNMF alternatives" section above for the current picks, or visit /alternatives/genenmf for the full list with editorial commentary on each.

What are the best alternatives to medrobust?

Top medrobust alternatives in Analytics are ranked by recent ship velocity. Browse the "medrobust alternatives" section above for the current picks, or visit /alternatives/medrobust for the full list with editorial commentary on each.